Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2019 07:00 ET | Source: Neovasc, Inc.

Neovasc Appoints Cardiovascular Industry Veteran Bill Little as Chief Operating Officer

Vancouver, Nov. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...
November 07, 2019 07:00 ET | Source: EVO Payments, Inc.

EVO Reports Third Quarter 2019 Results

ATLANTA, Nov. 07, 2019 (GLOBE NEWSWIRE) -- EVO Payments, Inc. (NASDAQ: EVOP) (“EVO” or the “Company”) today announced its third quarter 2019 financial results. For the third quarter ended September...
November 07, 2019 07:00 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update

THE WOODLANDS, Texas, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results and provided a business update for the three months ended...
November 07, 2019 07:00 ET | Source: Malibu Boats, Inc.

Malibu Boats, Inc. Announces First Quarter Fiscal 2020 Results

LOUDON, Tenn. , Nov. 07, 2019 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (Nasdaq: MBUU) today announced its financial results for the first quarter ended September 30, 2019. Highlights for the First...
November 07, 2019 07:00 ET | Source: Axsome Therapeutics, Inc.

Axsome Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update

GEMINI Phase 3 placebo-controlled trial of AXS-05 in MDD completed enrollment and on track for readout of topline results by year-end 2019 STRIDE-1 Phase 3 trial of AXS-05 in TRD to conclude patient...
November 07, 2019 07:00 ET | Source: Focus Financial Partners Inc.

Focus Financial Partners Reports Third Quarter 2019 Results

Year-Over-Year Revenue Growth above 30% Strong Results Across All Key Metrics NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Focus Financial Partners Inc. (Nasdaq: FOCS) (“Focus Inc.”, “Focus”, the...
November 07, 2019 07:00 ET | Source: BioCryst Pharmaceuticals, Inc.

Biocryst to Present Abstracts at Annual Scientific Meeting of American College of Allergy, Asthma & Immunology

RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present two abstracts at the upcoming Annual...
November 07, 2019 07:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics to Present at the New York Oncology Investor Conference

NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
November 07, 2019 07:00 ET | Source: Cyclacel

Cyclacel Pharmaceuticals to Release Third Quarter 2019 Financial Results

BERKELEY HEIGHTS, N.J., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
November 07, 2019 07:00 ET | Source: Beasley Broadcast Group, Inc.

Beasley Broadcast Group Reports Record Third Quarter Net Revenue of $66.1 Million

Conference Call and WebcastToday, November 7, 2019 at 10:00 a.m. ET334/323-0522, conference ID 2175708 or www.bbgi.comReplay information provided below NAPLES, Fla., Nov. 07, 2019 (GLOBE...